HPEPT1 is Responsible for Uptake and Transport of Gly-Sar in the Human Bronchial Airway Epithelial Cell-line Calu-3

Overview

Journal Pflugers Arch

Specialty Physiology

Date 2007 Dec 21

PMID 18094991

Citations 6

Authors

Helle Bach Sondergaard

Birger Brodin

Carsten Uhd Nielsen

Affiliations

Soon will be listed here.

Abstract

The purpose of this work was to investigate the apical uptake and transepithelial transport of Gly-Sar along with the expression of the di-/tripeptide transporters hPEPT1 and hPEPT2 in human Calu-3 bronchial epithelial cells. The apical Gly-Sar uptake rate in Calu-3 cells followed Michaelis-Menten kinetics with a Km value of 1.3 +/- 0.3 mM and a Vmax value of 0.60 +/- 0.06 nmol cm(-2) min(-1). Transepithelial apical to basolateral transport of 50 microM [3H]-labelled Gly-Sar across the Calu-3 cell monolayer was pH-dependent. The Gly-Sar flux was significantly reduced in the presence of delta-aminolevulinic acid (2.5 mM), cephalexin (25 mM), and captopril (25 mM; p < 0.05, n = 3). Reverse transcriptase polymerase chain reaction (RT-PCR) revealed the presence of both hPEPT1 and hPEPT2 mRNA in the Calu-3 cells. These findings were confirmed in healthy human bronchial cDNA. Restriction-endonuclease analysis identified hPEPT2 in Calu-3 cells to be the hPEPT2*1 haplotype. Western blotting demonstrated expression of the hPEPT1 protein (approximately 80 kDa), and the immunolabel was mainly localized in the apical membrane as judged by immunolocalization studies using confocal laser scanning microscopy (CLSM). This work presents for the first time hPEPT1 and hPEPT2*1 expression in human Calu-3 cells. Surprisingly, the results indicate that Gly-Sar uptake and transport in Calu-3 cells are hPEPT1-mediated rather than hPEPT2-mediated.

Citing Articles

Oligopeptide Transport in Rat Lung Alveolar Epithelial Cells is Mediated by Pept2.

Gukasyan H, Uchiyama T, Kim K, Ehrhardt C, Wu S, Borok Z Pharm Res. 2017; 34(12):2488-2497.

PMID: 28831683 DOI: 10.1007/s11095-017-2234-z.

Permeation of Therapeutic Drugs in Different Formulations across the Airway Epithelium In Vitro.

Meindl C, Stranzinger S, Dzidic N, Salar-Behzadi S, Mohr S, Zimmer A PLoS One. 2015; 10(8):e0135690.

PMID: 26274590 PMC: 4537286. DOI: 10.1371/journal.pone.0135690.

Functional Expression of PEPT2 in the Human Distal Lung Epithelial Cell Line NCl-H441.

Takano M, Sugimoto N, Ehrhardt C, Yumoto R Pharm Res. 2015; 32(12):3916-26.

PMID: 26168863 DOI: 10.1007/s11095-015-1751-x.

Epithelial monolayer culture system for real-time single-cell analyses.

Seo J, Moody M, Koh D Physiol Rep. 2014; 2(4):e12002.

PMID: 24771696 PMC: 4001881. DOI: 10.14814/phy2.12002.

Identification and Characterization of a Novel Nontranslated Sequence Variant of the Human Intestinal Di-/Tripeptide Transporter, hPEPT1.

Bach Sondergaard H, Nielsen C, Brodin B Int J Pept. 2013; 2012:743472.

PMID: 23346117 PMC: 3546484. DOI: 10.1155/2012/743472.

References

Helliwell P, Meredith D, Boyd C, BRONK J, Lister N, Bailey P . Tripeptide transport in rat lung. Biochim Biophys Acta. 1994; 1190(2):430-4. DOI: 10.1016/0005-2736(94)90104-x. View

Bravo S, Nielsen C, Frokjaer S, Brodin B . Characterization of rPEPT2-mediated Gly-Sar transport parameters in the rat kidney proximal tubule cell line SKPT-0193 cl.2 cultured in basic growth media. Mol Pharm. 2005; 2(2):98-108. DOI: 10.1021/mp049892q. View

Gonzalez D, Covitz K, Sadee W, Mrsny R . An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1 and Capan-2. Cancer Res. 1998; 58(3):519-25. View

Bretschneider B, Brandsch M, Neubert R . Intestinal transport of beta-lactam antibiotics: analysis of the affinity at the H+/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux. Pharm Res. 1999; 16(1):55-61. DOI: 10.1023/a:1018814627484. View

Nielsen C, Amstrup J, Steffansen B, Frokjaer S, Brodin B . Epidermal growth factor inhibits glycylsarcosine transport and hPepT1 expression in a human intestinal cell line. Am J Physiol Gastrointest Liver Physiol. 2001; 281(1):G191-9. DOI: 10.1152/ajpgi.2001.281.1.G191. View

Foster K, Avery M, Yazdanian M, Audus K . Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery. Int J Pharm. 2000; 208(1-2):1-11. DOI: 10.1016/s0378-5173(00)00452-x. View

Groneberg D, Eynott P, Doring F, Dinh Q, Oates T, Barnes P . Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung. Thorax. 2002; 57(1):55-60. PMC: 1746169. DOI: 10.1136/thorax.57.1.55. View

Saito H, Okuda M, Terada T, Sasaki S, Inui K . Cloning and characterization of a rat H+/peptide cotransporter mediating absorption of beta-lactam antibiotics in the intestine and kidney. J Pharmacol Exp Ther. 1995; 275(3):1631-7. View

Liang R, Fei Y, Prasad P, Ramamoorthy S, Han H, Yang-Feng T . Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization. J Biol Chem. 1995; 270(12):6456-63. DOI: 10.1074/jbc.270.12.6456. View

10.

Cheng Y, Prusoff W . Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973; 22(23):3099-108. DOI: 10.1016/0006-2952(73)90196-2. View

11.

Florea B, Cassara M, Junginger H, Borchard G . Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3. J Control Release. 2003; 87(1-3):131-8. DOI: 10.1016/s0168-3659(02)00356-5. View

12.

Vabeno J, Lejon T, Nielsen C, Steffansen B, Chen W, Ouyang H . Phe-Gly dipeptidomimetics designed for the di-/tripeptide transporters PEPT1 and PEPT2: synthesis and biological investigations. J Med Chem. 2004; 47(4):1060-9. DOI: 10.1021/jm031022+. View

13.

Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky K . 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer. 1997; 79(12):2282-308. DOI: 10.1002/(sici)1097-0142(19970615)79:12<2282::aid-cncr2>3.0.co;2-o. View

14.

Temple C, Boyd C . Proton-coupled oligopeptide transport by rat renal cortical brush border membrane vesicles: a functional analysis using ACE inhibitors to determine the isoform of the transporter. Biochim Biophys Acta. 1998; 1373(1):277-81. DOI: 10.1016/s0005-2736(98)00093-5. View

15.

Brandsch M, Knutter I, Thunecke F, Hartrodt B, Born I, Borner V . Decisive structural determinants for the interaction of proline derivatives with the intestinal H+/peptide symporter. Eur J Biochem. 1999; 266(2):502-8. DOI: 10.1046/j.1432-1327.1999.00885.x. View

16.

Biegel A, Knutter I, Hartrodt B, Gebauer S, Theis S, Luckner P . The renal type H+/peptide symporter PEPT2: structure-affinity relationships. Amino Acids. 2006; 31(2):137-56. DOI: 10.1007/s00726-006-0331-0. View

17.

Liu W, Liang R, Ramamoorthy S, Fei Y, Ganapathy M, Hediger M . Molecular cloning of PEPT 2, a new member of the H+/peptide cotransporter family, from human kidney. Biochim Biophys Acta. 1995; 1235(2):461-6. DOI: 10.1016/0005-2736(95)80036-f. View

18.

Sakagami M . In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev. 2006; 58(9-10):1030-60. DOI: 10.1016/j.addr.2006.07.012. View

19.

Labiris N, Dolovich M . Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 2003; 56(6):588-99. PMC: 1884307. DOI: 10.1046/j.1365-2125.2003.01892.x. View

20.

Bahadduri P, DSouza V, Pinsonneault J, Sadee W, Bao S, Knoell D . Functional characterization of the peptide transporter PEPT2 in primary cultures of human upper airway epithelium. Am J Respir Cell Mol Biol. 2005; 32(4):319-25. DOI: 10.1165/rcmb.2004-0322OC. View